Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem Pharmacol
2011 Oct 15;828:904-14. doi: 10.1016/j.bcp.2011.06.018.
Show Gene links
Show Anatomy links
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.
Araud T
,
Graw S
,
Berger R
,
Lee M
,
Neveu E
,
Bertrand D
,
Leonard S
.
???displayArticle.abstract???
The human α7 neuronal nicotinic acetylcholine receptor gene (CHRNA7) is a candidate gene for schizophrenia and an important drug target for cognitive deficits in the disorder. Activation of the α7*nAChR, results in opening of the channel and entry of mono- and divalent cations, including Ca(2+), that presynaptically participates to neurotransmitter release and postsynaptically to down-stream changes in gene expression. Schizophrenic patients have low levels of α7*nAChR, as measured by binding of the ligand [(125)I]-α-bungarotoxin (I-BTX). The structure of the gene, CHRNA7, is complex. During evolution, CHRNA7 was partially duplicated as a chimeric gene (CHRFAM7A), which is expressed in the human brain and elsewhere in the body. The association between a 2bp deletion in CHRFAM7A and schizophrenia suggested that this duplicate gene might contribute to cognitive impairment. To examine the putative contribution of CHRFAM7A on receptor function, co-expression of α7 and the duplicate genes was carried out in cell lines and Xenopus oocytes. Expression of the duplicate alone yielded protein expression but no functional receptor and co-expression with α7 caused a significant reduction of the amplitude of the ACh-evoked currents. Reduced current amplitude was not correlated with a reduction of I-BTX binding, suggesting the presence of non-functional (ACh-silent) receptors. This hypothesis is supported by a larger increase of the ACh-evoked current by the allosteric modulator 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596) in cells expressing the duplicate than in the control. These results suggest that CHRFAM7A acts as a dominant negative modulator of CHRNA7 function and is critical for receptor regulation in humans.
Adler,
Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
1993, Pubmed
Adler,
Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
1993,
Pubmed
Benfante,
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.
2011,
Pubmed
Bertolino,
Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus.
1997,
Pubmed
Bertrand,
Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment.
2008,
Pubmed
,
Xenbase
Biedler,
Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.
1973,
Pubmed
Chimienti,
Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda.
2003,
Pubmed
,
Xenbase
Conroy,
PDZ-containing proteins provide a functional postsynaptic scaffold for nicotinic receptors in neurons.
2003,
Pubmed
Court,
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.
1999,
Pubmed
Dani,
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
2007,
Pubmed
De Luca,
Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.
2004,
Pubmed
de Lucas-Cerrillo,
Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response.
2011,
Pubmed
,
Xenbase
Dempster,
Episodic memory performance predicted by the 2bp deletion in exon 6 of the "alpha 7-like" nicotinic receptor subunit gene.
2006,
Pubmed
Fallin,
Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.
2003,
Pubmed
Faraone,
A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families.
2004,
Pubmed
Fisher,
Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component.
2000,
Pubmed
Flomen,
Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder.
2006,
Pubmed
Flomen,
The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion.
2008,
Pubmed
Freedman,
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.
1995,
Pubmed
Freedman,
Evidence for the multigenic inheritance of schizophrenia.
2001,
Pubmed
Freedman,
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.
1997,
Pubmed
Gallowitsch-Puerta,
Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor.
2005,
Pubmed
Gault,
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects.
2003,
Pubmed
Gault,
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7).
1998,
Pubmed
Gejman,
Linkage analysis of schizophrenia to chromosome 15.
2001,
Pubmed
George,
Effects of smoking abstinence on visuospatial working memory function in schizophrenia.
2002,
Pubmed
Green,
Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially.
1993,
Pubmed
Guan,
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain.
1999,
Pubmed
Harrison,
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.
2005,
Pubmed
Hoda,
Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.
2008,
Pubmed
,
Xenbase
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Hogg,
Nicotinic acetylcholine receptors: from structure to brain function.
2003,
Pubmed
Hsiao,
Activation of the maternal immune system induces endocrine changes in the placenta via IL-6.
2011,
Pubmed
Hurst,
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
2005,
Pubmed
,
Xenbase
International Schizophrenia Consortium,
Rare chromosomal deletions and duplications increase risk of schizophrenia.
2008,
Pubmed
Jones,
Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area.
2004,
Pubmed
Kaufmann,
NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees.
1998,
Pubmed
Kumari,
Nicotine use in schizophrenia: the self medication hypotheses.
2005,
Pubmed
Le Novère,
The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.
2002,
Pubmed
Leonard,
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.
2002,
Pubmed
Leonard,
Genetics of chromosome 15q13-q14 in schizophrenia.
2006,
Pubmed
Leonard,
Smoking, Genetics and Schizophrenia: Evidence for Self Medication.
2007,
Pubmed
Levy,
Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex.
2002,
Pubmed
Liu,
Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families.
2001,
Pubmed
Locke,
Refinement of a chimpanzee pericentric inversion breakpoint to a segmental duplication cluster.
2003,
Pubmed
Locke,
Molecular evolution of the human chromosome 15 pericentromeric region.
2005,
Pubmed
Marks,
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
1986,
Pubmed
Marutle,
Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.
1998,
Pubmed
Marutle,
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.
2001,
Pubmed
McGehee,
Presynaptic ionotropic receptors.
1996,
Pubmed
Mexal,
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers.
2005,
Pubmed
Mexal,
Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.
2010,
Pubmed
Meyer,
Neural basis of psychosis-related behaviour in the infection model of schizophrenia.
2009,
Pubmed
Miwa,
The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo.
2006,
Pubmed
Miwa,
lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.
1999,
Pubmed
,
Xenbase
Morishita,
Lynx1, a cholinergic brake, limits plasticity in adult visual cortex.
2010,
Pubmed
Orr-Urtreger,
Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.
1997,
Pubmed
Ortells,
Evolutionary history of the ligand-gated ion-channel superfamily of receptors.
1995,
Pubmed
Patterson,
Immune involvement in schizophrenia and autism: etiology, pathology and animal models.
2009,
Pubmed
Pavlov,
Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
2009,
Pubmed
Petrovsky,
CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance.
2009,
Pubmed
Quik,
Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.
1996,
Pubmed
Raux,
The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit.
2002,
Pubmed
Rezvani,
Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats.
2003,
Pubmed
Riley,
Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families.
2000,
Pubmed
Riley,
A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14.
2002,
Pubmed
Rosas-Ballina,
Cholinergic control of inflammation.
2009,
Pubmed
Rosas-Ballina,
The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.
2009,
Pubmed
Rousseau,
Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
2005,
Pubmed
Schilström,
Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area.
2000,
Pubmed
Simon,
Q-Gene: processing quantitative real-time RT-PCR data.
2003,
Pubmed
Sinkus,
A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.
2009,
Pubmed
Stefansson,
Large recurrent microdeletions associated with schizophrenia.
2008,
Pubmed
Stephens,
Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia.
2009,
Pubmed
Stephens,
Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.
2012,
Pubmed
Taly,
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
2009,
Pubmed
Tanibuchi,
Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
2010,
Pubmed
Toyohara,
Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
2009,
Pubmed
Tregellas,
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia.
2011,
Pubmed
Tsuang,
Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample.
2001,
Pubmed
Tsuneki,
Novel G423S mutation of human alpha7 nicotinic receptor promotes agonist-induced desensitization by a protein kinase C-dependent mechanism.
2007,
Pubmed
,
Xenbase
Tsunoyama,
Evolution of nicotinic acetylcholine receptor subunits.
1998,
Pubmed
Villiger,
Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes.
2002,
Pubmed
Xu,
Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families.
2001,
Pubmed
